TCB
ELV icon

Texas Capital Bancshares’s Elevance Health ELV Stock Holding History

Texas Capital Bancshares’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$14.5K Buy
+45
New +$14K 0.01% 133

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Texas Capital Bancshares's ELV Position: Q3 2025 in Review

Texas Capital Bancshares opened a new position in Elevance Health (ELV) in Q3 2025: 45 shares worth $14.5K. The stake represents 0.01% of the portfolio and ranks #133 among its holdings.

1,511 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Texas Capital Bancshares held 45 shares of Elevance Health worth $14.5K as of Q3 2025.
  • Elevance Health was a new Texas Capital Bancshares position in Q3 2025.
  • Elevance Health made up 0.01% of Texas Capital Bancshares's portfolio in Q3 2025, its #133 holding.
  • 1,511 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Texas Capital Bancshares's 13F filing for Q3 2025, filed 13 Nov 2025.